PT - JOURNAL ARTICLE AU - Barra, María Ana AU - Carlos Medinacelli, Nelson Adolfo AU - Meza Padilla, Camilo Andres AU - Di Rocco, Lucrecia AU - Larrea, Ramiro Manuel AU - Gaudenzi, Giuliano AU - Mastrovincenzo, Verónica Vanesa AU - Raña, Elisa AU - Moreno, Inés AU - Sörvik, Dagmar Ana AU - Sarlingo, Andrea AU - Dadomo, Florencia AU - Torrilla, Miguel TI - COVID-19 in hospitalized patients in 4 hospitals in San Isidro, Buenos Aires, Argentina AID - 10.1101/2021.07.30.21261220 DP - 2021 Jan 01 TA - medRxiv PG - 2021.07.30.21261220 4099 - http://medrxiv.org/content/early/2021/08/14/2021.07.30.21261220.short 4100 - http://medrxiv.org/content/early/2021/08/14/2021.07.30.21261220.full AB - In December 2019, a novel illness called coronavirus disease 2019 (COVID-19) was described in China and became pandemic in a few months. The first case was detected in Argentina on March 3, 2020.A multicentre prospective observational cohort study on hospitalized patients with COVID- 19 was conducted in 4 hospitals in San Isidro district from March 1, 2020 to October 31. Data was obtained by the attendant physician. 668 patients were included, the median age was 54 years, and 42.7% were female. Male sex and older age were associated with COVID-19 disease and more strongly with severity. Most frequent symptoms were fever and cough followed by dyspnoea, myalgia, odynophagia, headache, anosmia, and diarrhoea. Non-severe patients had more upper respiratory symptoms while severe patients had mainly lower respiratory symptoms on admission. Most common comorbidities were arterial hypertension, diabetes, and cardiovascular disease. A great proportion of patients had normal thorax X-ray and ground-glass opacity in tomography. In severe patients, radiography and tomography had a predominant ground – glass pattern, but normal radiography and tomography on presentation were present in 22% and 5.9%, respectively. The absence of fever and normal radiology on admission neither excluded the disease nor further severity. PCR elevation was related with COVID-19 disease and with severity, while lymphopenia was more related with the disease and leukocytosis and thrombocytopenia with severity. 8, 4% of patients were health care workers. The mortality rate was 12.4%, 32.7% in severe patients and 61.2% in ventilated patients. Mortality was higher in the public hospital, probably associated with patients with older age and more comorbidities. All these observations can contribute to the knowledge of this disease in terms of diagnosis and prognosis.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://doi.org/10.6084/m9.figshare.15062484.v2 Funding StatementNo funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Institutional Evaluation Committee of the Austral Hospital registered in the Office of Human Research Protections IORG0006075 IRB00007319 Universidad Austral IRB and in the Buenos Aires Province Central Ethic CommitteeAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll Data available at link figshare https://doi.org/10.6084/m9.figshare.15062484.v2